Changes of mitochondrial ultrastructures and function in central nervous tissue of hens treated with tri-ortho-cresyl phosphate (TOCP)

Abstract

Tri-ortho-cresyl phosphate (TOCP), an organophosphorus ester, is capable of producing organophosphorus ester-induced delayed neurotoxicity (OPIDN) in humans and sensitive animals. The mechanism of OPIDN has not been fully understood. The present study has been designed to evaluate the role of mitochondrial dysfunctions in the development of OPIDN. Adult hens were treated with 750 mg/kg·bw TOCP by gavage and control hens were given an equivalent volume of corn oil. On day 1, 5, 15, 21 post-dosing, respectively, hens were anesthetized by intraperitoneal injection of sodium pentobarbital and perfused with 4% paraformaldehyde. The cerebral cortex cinerea and the ventral horn of lumbar spinal cord were dissected for electron microscopy. Another batch of hens were randomly divided into three experimental groups and control group. Hens in experimental groups were, respectively, given 185, 375, 750 mg/kg·bw TOCP orally and control group received solvent. After 1, 5, 15, 21 days of administration, they were sacrificed and the cerebrum and spinal cord dissected for the determination of the mitochondrial permeability transition (MPT), membrane potential (Δψ_m) and the activity of succinate dehydrogenase. Structural changes of mitochondria were observed in hens’ nervous tissues, including vacuolation and fission, which increased with time post-dosing. MPT was increased in both the cerebrum and spinal cord, with the most noticeable increase in the spinal cord. Δψ_m was decreased in both the cerebrum and spinal cord, although there was no significant difference in the three treated groups and control group. The activity of mitochondrial succinate dehydrogenase assayed by methyl thiazolyl tetrazolium (MTT) reduction also confirmed mitochondrial dysfunctions following development of OPIDN. The results suggested mitochondrial dysfunction might partly account for the development of OPIDN induced by TOCP.

Keywords

tri-ortho-cresyl phosphate (TOCP)organophosphorus ester-induced delayed neurotoxicity (OPIDN)morphological changes mitochondrial permeability transition (MPT)methyl thiazolyl tetrazolium (MTT) reduction

References

Abou-Donia MB Organophosphorus ester-induced delayed neurotoxicity . Annu Rev Pharmacol Toxicol 1981; 21: 511-548.

Lotti M. The pathogenesis of organophosphate neuropathy. Crit Rev Toxicol 1991; 21: 465-487.

Lotti M. , Moretto A. Organophosphate-induced delayed polyneuropathy. Toxicol Rev 2005; 24: 37-49.

Cavanagh JB Peripheral nerve changes in ortho-cresyl phosphate poisoning in the cat. Pathol Bacteriol 1964; 87: 365-383.

Jamal GA Neurological syndromes of organophosphorus compounds. Adverse Drug React Toxicol Rev 1997; 16: 133-170.

Bischoff A. The ultrastructure of tri-ortho-cresyl phosphate in poisoning. I. Studies on myelin and axonal alterations in the sciatic nerve. Acta Neuropathol 1967; 9: 158-174.

Bischoff A. Ultrastructure of tri-ortho-cresyl phosphate poisoning in the chickens. II. Studies on spinal cord alterations. Acta Neuropathol 1970; 15: 142-155.

Pop-Busui R. , Sima A. , and Stevens M. Diabetic neuropathy and oxidative stress. Diabetes Metab Res Rev 2006; 22: 257-273.

Mancuso M. , Coppede F. , Migliore L. , Siciliano G. , and Murri L. Mitochondrial dysfunction, oxidative stress and neurodegeneration . Alzheimers Dis 2006; 10: 59-73.

10.

Lin MT , Beal MF Mitochondrial dysfunction and oxidative stress in neurodegenerative disease . Nature 2006; 443: 787-795.

11.

Massicotte C. , Knight K. , Van der Schyf CJ , Jortner BS , and Ehrich M. Effects of organophosphorus compounds on ATP production and mitochondrial integrity in cultured cells . Neurotoxicol Res 2005; 7: 203-217.

12.

Chan JY , Chan SH , Dai KY , Cheng HL , Chou JL , and Chang AY Cholinergic-receptor-independent dysfunction of mitochondrial respiratory chain enzymes, reduced mitochondrial transmembrane potential and ATP depletion underlie necrotic cell death induced by the organophosphate poison mevinphos . Neuropharmacology 2006; 51: 1109-1119.

13.

Massicotte C. , Barber DS , Jortner BS , and Ehrich M. Nerve conduction and ATP concentrations in sciatic-tibial and medial plantar nerves of hens given phenyl saligenin phosphate . Neurotoxicology 2001; 22: 91-98.

14.

Mou DL , Wang YP , Song JF , Rao ZR , Duan L. , and Ju G. Triorthocresyl phosphate-induced neuronal losses in lumbar spinal cord of hens-an immunohistochemistry and ultrastructure study. Int J Neuroscience 2006; 116: 1303-1316.

15.

Kaur P. , Radotra B. , Minz RW , and Gill KD Impaired mitochondrial energy metabolism and neuronal apoptotic cell death after chronic dichlorvos (OP) exposure in rat brain. Neurotoxicology 2007; 28: 1208-1219.

16.

Pope CN , Padilla S. Potentiation of organophosphorus-induced delayed neurotoxicity by phenylmethylsulfonyl fluoride. Toxicol Environ Health 1990; 31: 261-273.

17.

Clark JB , Nicklas WJ The metabolism of rat brain mitochondria. Preparation and characterization . Biol Chem 1970; 245: 4724-4731.

18.

Uyemura SA , Santos AC , Mingatto FE , Jordani MC , and Curti C. Diclofenac sodium and mefenamic acid: potent inducers of the membrane permeability transition in renal cortex mitochondria. Arch Biochem Biophys 1997; 342: 231-235.

19.

Zeng T. , Zhang CL , Zhu ZP , Yu LH , Zhao XL , and Xie KQ Diallyl trisulfide (DATS) effectively attenuated oxidative stress-mediated liver injury and hepatic mitochondrial dysfunction in acute ethanol-exposed mice. Toxicology 2008; 252: 86-91.

20.

Emaus RK , Grunwald R. , and Lemasters JJ Rhodamine 123 as a probe of transmembrane potential in isolated rat-liver mitochondria: spectral and metabolic properties. Biochim Biophys Acta 1986; 85: 436-448.

21.

Masoud A. , Kiran R. , and Sandhir R. Impaired mitochondrial functions in organophosphate induced delayed neuropathy in rats. Cell Mol Neurobiol 2009 ; 29: 1245-1255.

22.

Holzbaur EL Motor neurons rely on motor proteins. Trends Cell Biol 2004; 14: 233-240.

23.

Griffin JW , Watson DF Axonal transport in neurological disease. Ann Neurol 1988; 23: 3-13.

24.

Moretto A. , Sabri MI Progressive deficits in retrograde axon transport precede degeneration of motor neuron in acrylamide neuropathy. Brain Res 1988; 440: 18-24.

25.

Sabri MI , Ederle K. , Holdsworth CE , and Spencer PS Studies on the biochemical basis of distal axonopathies. II. Specific inhibition of fructose-6-phosphate kinase by 2, 5-hexanedione and methyl-butyl ketone . Neurotoxicology 1979; 1: 1-11.

26.

Sabri MI , Moore CL , and Spencer PS Studies on the biochemical basis of distal axonopathies. I. Inhibition of glycolysis by neurotoxic hexacarbone compounds. Neurochemistry 1979; 32: 683-689.

27.

Smith RAJ , Porteous CM , and Murphy CM Selective targeting of an antioxidant to mitochondria. Eur J Biochem 1999; 263: 709-716.

28.

Zhou JF , Zhou W. , Zhang SM , Luo YE , and Chen HH Oxidative stress and free radical damage in patients with acute dipterex poisoning . Biomed Environ Sci 2004; 17: 223-233.

29.

Szeto HH Mitochondria-targeted peptide antioxidants: novel neuroprotective agents. AAPS 2006; 8: E521- E531.

30.

Zhang LP , Wang QS , Guo X. , Zhu YJ , Zhou GZ , and Xie KQ Time-dependent changes of lipid peroxidation and antioxidative status in nerve tissues of hens treated with tri-ortho-cresyl phosphate (TOCP). Toxicology 2007; 239: 45-52.

31.

Susin SA , Zamzami N. , and Kroemer G. Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta 1998; 1366: 151-165.

32.

Grimm S. , Bradiczka D. The permeability transition pore in cell death. Apoptosis 2007; 12: 841-855.

33.

Sullivan PG , Rabchevsky AG , Waldmeier PC , and Springer JE

Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death?

J Neurosci Res 2005; 79: 231-239.

34.

Tsujimoto Y. , Shimizu S. Role of the mitochondrial membrane permeability transition in cell death. Apoptosis 2007; 12: 835-840.

35.

Friberg H. , Wieloch T. Mitochondrial permeability transition in acute neurodegeneration. Biochimie 2002; 84: 241-250.

36.

Mazzeo AT , Beat A. , Singh A. , and Bullock MR The role of mitochondrial transition pore, and its modulation, in traumatic brain injury and delayed neurodegeneration after TBI. Rev Exper Neurol 2009; 218: 363-370.

37.

Glynn P. Neural development and neurodegeneration: two faces of neuropathy target esterase . Prog Neurobiol 2000; 61: 61-74.

38.

Lopachin RM , Lehning EJ Mechanism of calcium entry during axon injury and degeneration. Toxicol Appl Pharmacol 1997 ; 143: 233-244.